China Pharma Holdings (CPHI) Raw Materials (2017 - 2024)

China Pharma Holdings' Raw Materials history runs 8 years deep, the most recent figure standing at $869820.0 for Q3 2024.

• Quarterly Raw Materials fell 53.69% year-over-year to $869820.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $869820.0 (down 53.69% YoY) and the FY2023 annual result came in at $1.8 million, up 0.52% from the prior year.
• Raw Materials was $869820.0 for Q3 2024 at China Pharma Holdings, down from $1.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $2.2 million in Q1 2023 and bottomed at $869820.0 in Q3 2024.
• A 5-year average of $1.8 million and a median of $1.8 million in 2021 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2023 — Raw Materials increased 20.5% — and 2024, when it sank 53.69%.
• China Pharma Holdings' Raw Materials stood at $2.1 million in 2020, then fell by 11.63% to $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then climbed by 0.52% to $1.8 million in 2023, then tumbled by 52.96% to $869820.0 in 2024.
• Business Quant data shows CPHI's Raw Materials at $869820.0 in Q3 2024, $1.2 million in Q2 2024, and $1.7 million in Q1 2024.